Exploring Rosiglitazone’s Potential to Treat Alzheimer’s Disease through the Modulation of Brain-Derived Neurotrophic Factor

SIMPLE SUMMARY: This review focuses on rosiglitazone, a medication used to treat diabetes. Rosiglitazone lowers blood sugar levels by helping the body use insulin more efficiently. Individuals with diabetes have a higher risk of developing Alzheimer’s disease, a complex memory-loss disorder affectin...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Mackayla L., Pfeifer, Julia A., Hickey, Jordan P., Collins, Andrila E., Kalisch, Bettina E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376118/
https://www.ncbi.nlm.nih.gov/pubmed/37508471
http://dx.doi.org/10.3390/biology12071042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376118/
https://www.ncbi.nlm.nih.gov/pubmed/37508471
http://dx.doi.org/10.3390/biology12071042

Ejemplares similares